Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines)

Hepatology Research

Volumn 45, Issue 2, 2015, Pages 123-127

  Kokudo, Norihiro ^a   Hasegawa, Kiyoshi ^a   Akahane, Masaaki ^a   Igaki, Hiroshi ^a   Izumi, Namiki ^a   Ichida, Takafumi ^a   Uemoto, Shinji ^a   Kaneko, Shuichi ^a   Kawasaki, Seiji ^a   Ku, Yonson ^a   Kudo, Masatoshi ^a   Kubo, Shoji ^a   Takayama, Tadatoshi ^a   Tateishi, Ryosuke ^a   Fukuda, Takashi ^a   Matsui, Osamu ^a   Matsuyama, Yutaka ^a   Murakami, Takamichi ^a   Arii, Shigeki ^a   Okazaki, Masatoshi ^a   Makuuchi, Masatoshi ^a   more..

^a The Committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma   (Japan)

Author keywords

Algorithm for surveillance and diagnosis; Algorithm for treatment; Clinical practice guidelines; Clinical question; Evidence based medicine

Indexed keywords

ALPHA FETOPROTEIN; TUMOR MARKER;

ABLATION THERAPY; ALGORITHM; ARTICLE; ARTIFICIAL EMBOLISM; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PALLIATIVE THERAPY; CANCER SURGERY; CHILD PUGH SCORE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; EVIDENCE BASED MEDICINE; EVIDENCE BASED PRACTICE; HEALTH CARE POLICY; HIGH RISK POPULATION; HUMAN; JAPAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; MEDICAL DECISION MAKING; MEDICAL SOCIETY; MEDICAL SPECIALIST; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIODIC MEDICAL EXAMINATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; TUMOR VOLUME; ULTRASOUND;

EID: 84921454545     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/hepr.12464     Document Type: Article

References (13)

1. Makuuchi M, Kokudo N. Clinical practice guidelines for hepatocellular carcinoma - The Japan Society of Hepatology 2009 update. Hepatol Res 2010; 40 (Suppl. 1): 2-144.
2. Makuuchi M, Kokudo N. Clinical practice guidelines for hepatocellular carcinoma: the first evidence-based guidelines Japan. World J Gastroenterol 2006; 12: 828-829.
3. Makuuchi M, Kokudo N, Arii S etal. Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatol Res 2008; 38: 37-51.
4. Kokudo N, Makuuchi M. Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: the J-HCC guidelines. J Gastroenterol 2009; 44 (Suppl. 19): 119-121.
5. Bruix J, Sherman M, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020-1022.
6. Hasegawa K, Makuuchi M, Takayama T etal. Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey. J Hepatol 2008; 49: 589-594.
7. Hasegawa K, Kokudo N, Makuuchi M etal. Comparison of resection and ablation for hepatocellular carcinoma: a cohort study based on a Japanese nationwide survey. J Hepatol 2013; 58: 724-729.
8. Huang GT, Lee PH, Tsang YM etal. Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study. Ann Surg 2005; 242 (1): 36-42.
9. Chen MS, Li JQ, Zheng Y etal. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 2006; 243: 321-328.
10. Huang J, Yan L, Cheng Z etal. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg 2010; 252: 903-912.
11. Hasegawa K, Kokudo N, Makuuchi M. Surgery or ablation for hepatocellular carcinoma? Ann Surg 2008; 247: 557-558.
12. Llovet JM, Ricci S, Mazzaferro V etal. for SHARP Investigators Study Group. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008; 359 (4): 378-390.
13. Omata M, Lesmana LA, Tateishi R etal. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 2010; 4: 439-474.